EUVIMEDEUVIMED entdecken
Crossref

Addition of Curcumin‐QingDai correlates with clinical benefit in pediatric ulcerative colitis and inflammatory bowel disease‐unclassified

Francesca Sadovi iD, Jiafeng Li iD, Amanda Gomez, Jonathan Cordova iD, Joshua Prozialeck iD, Jennifer Strople, Jeffrey Brown iD, Joseph Runde iD

Journal of Pediatric Gastroenterology and Nutrition · 17.11.2026

DOI: 10.1002/jpn3.70683 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, online erschienen am 17.11.2026. Verfasst von Francesca Sadovi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Robert Louis Katz & Manne Research Institute Summer Scholars Program, Northwestern Medicine, Chicago, Illinois, USA. Die Arbeit nennt 21 Literaturangaben. Gefördert von: None, General Motors Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Composite remission remains hard to achieve for patients with inflammatory bowel disease (IBD). Recently, a novel herbal‐based combination therapy, Curcumin‐QingDai (CurQD), has shown promise in improving rates of clinical remission for adults with ulcerative colitis (UC), however, experience in children is lacking. Here we describe efficacy and safety of CurQD in a pediatric cohort diagnosed with UC/IBD‐unclassified (IBD‐U).

Methods

We performed a retrospective chart review of children with a diagnosis of UC or IBD‐U beginning CurQD. Data collection included demographics, disease extent and severity, medication history, surgical history, biomarkers, endoscopic and histologic reports, and intestinal ultrasound. Clinical disease activity measured by the pediatric ulcerative colitis activity index (PUCAI) was recorded at baseline, Weeks 8–12 and Week 24.

Results

A total of 35 patients with UC/IBD‐U treated with CurQD met inclusion criteria, 28.6% were female and 62.9% had a diagnosis of UC. The median age at start of intervention was 14.0 years. Twenty‐two (62.9%) were bio‐experienced. Clinical response and clinical remission rates were 65.5% and 63.6%, respectively, by Week 24. Significant changes in calprotectin, ESR, albumin and hemoglobin were noted pre/post intervention. Side effects to CurQD were uncommon (14.2%) and mild in all cases.

Conclusions

As management options in the pediatric population are limited, adjunctive therapy is often a crucial consideration in achieving clinical response in children with IBD. Our data suggests that the addition of CurQD may offer a safe and effective option for children with UC/IBD‐U when a primary agent has not resulted in a durable clinical remission.

Schlagwörter

Stichwörter der Autor:innen

CurQDadjunctive therapyclinical response/remissionnutraceutical

Autor:innen und Institutionen

  • Robert Louis Katz & Manne Research Institute Summer Scholars Program, Northwestern Medicine, Chicago, Illinois, USA.
  • Stanley Manne Children's Research Institute, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Division of Gastroenterology, Hepatology & Nutrition, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
  • Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.

ORCID-Profile: Francesca Sadovi, Jiafeng Li, Jonathan Cordova, Joshua Prozialeck, Jeffrey Brown, Joseph Runde

Förderung

  • None
  • General Motors Corporation

Zitieren

APA

Sadovi, F., Li, J., Gomez, A., Cordova, J., Prozialeck, J., Strople, J., Brown, J., & Runde, J. (2026). Addition of Curcumin‐QingDai correlates with clinical benefit in pediatric ulcerative colitis and inflammatory bowel disease‐unclassified. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.70683

Vancouver

Sadovi F, Li J, Gomez A, Cordova J, Prozialeck J, Strople J, et al. Addition of Curcumin‐QingDai correlates with clinical benefit in pediatric ulcerative colitis and inflammatory bowel disease‐unclassified. Journal of Pediatric Gastroenterology and Nutrition. 2026. doi:10.1002/jpn3.70683

BibTeX
@article{Sadovi2026,
  author = {Sadovi, Francesca and Li, Jiafeng and Gomez, Amanda and Cordova, Jonathan and Prozialeck, Joshua and Strople, Jennifer and Brown, Jeffrey and Runde, Joseph},
  title = {Addition of Curcumin‐QingDai correlates with clinical benefit in pediatric ulcerative colitis and inflammatory bowel disease‐unclassified},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2026},
  doi = {10.1002/jpn3.70683}
}
Kostenlos starten →